查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1531866

2024 年弱視全球市場報告

Amblyopia Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年弱視市場規模將穩定成長。 2028年，這一數字將以4.7%的複合年成長率成長至55.9億美元。預測期內的成長是由數位健康平台的擴展、資源和家長支持的增加、對兒童預防性保健的更多關注、對低視力的認知提高、眼科專科中心和診所的激增等推動的。這段時期的主要趨勢包括診斷技術的進步、新型治療方法的開發、我們對視覺發育和神經可塑性理解的進步以及新藥的引進和核准。

眼科疾病盛行率的增加預計將推動未來低視力市場的成長。眼科疾病包括多種影響眼睛的疾病，從白內障和青光眼等常見疾病到色素性視網膜炎和眼腫瘤等罕見疾病。導致這些疾病增加的因素包括螢幕時間增加、人口老化以及污染等環境因素。尤其是弱視，由於大腦開始忽略較弱眼睛的輸入，弱視會加重眼部疾病，如果不及時治療，可能會導致永久性視力喪失和深度知覺問題。根據美國疾病管制與預防美國(CDC) 的數據，截至 2024 年 1 月，超過 340 萬 40 歲以上的美國人失明或視力受損，預計到 2030 年這一數字將增加一倍。因此，眼科疾病盛行率的上升是推動弱視市場成長的促進因素。

低視力市場的主要企業正在優先考慮數位治療等治療技術的進步，以便為患者提供更好的治療。數位療法是透過先進軟體程式進行的實證干預措施，旨在預防、管理和治療醫學疾病。數位療法通常由數位平台推動，利用行為和生活方式的改變來改善健康結果，可以獨立使用，也可以與傳統治療方法同時使用。例如，美國生物技術公司 Luminopia Inc. 的數位治療藥物「Luminopia One」於 2021 年 9 月獲得 FDA核准。這種創新治療方法利用電視節目來增強被診斷為弱視的兒童的視力，是 FDA核准的第一個針對兒童神經視覺障礙的數位治療方法，也是第一個治療方法。次改編電視節目。一項針對 105 名兒童的 3 期臨床試驗結果顯示，與對照組相比，接受治療的兒童的視力有統計學上的顯著改善，平均視力分別為 1.8 線和 0.8 線。此外，62% 的接受治療的患者有良好的反應，定義為 2 條或更多線的改善，而對照組的比例為 33%。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球低視力市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球低視力市場表現：規模與成長，2018-2023
  • 全球低視力市場預測：規模與成長，2023-2028，2033F

第6章 市場細分

  • 全球低視力市場：依疾病類型分類的表現與預測，2018-2023、2023-2028F、2033F
  • 斜視性弱視
  • 屈光弱視
  • 剝奪性弱視
  • 逆轉弱視
  • 全球低視力市場：診斷表現與預測，2018-2023、2023-2028F、2033F
  • 視力檢查
  • 照片篩選器
  • 布魯克納測試
  • 其他診斷
  • 全球低視力市場：依治療分類的表現與預測，2018-2023、2023-2028F、2033F
  • 眼罩
  • 阿托品眼藥水
  • 眼鏡
  • 電玩遊戲
  • 其他治療方法
  • 全球低視力市場：最終使用者的表現與預測，2018-2023、2023-2028F、2033F
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第 7 章 區域/國家分析

  • 全球低視力市場：依地區分類的表現與預測，2018-2023、2023-2028F、2033F
  • 全球低視力市場：按國家分類的表現和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 弱視市場：競爭格局
  • 弱視市場：公司簡介
    • Novartis AG
    • Takeda Pharmaceutical Company Limited
    • Biocon Limited
    • Astellas Pharma Inc.
    • Alcon Vision LLC

第31章 其他重大及創新企業

  • Bausch Health Companies Inc.
  • HOYA Corp.
  • UnityPoint Health
  • Integra LifeSciences
  • Wockhardt Ltd.
  • Welch Allyn
  • Heidelberg Engineering Inc.
  • Orbis International
  • Oculus Optikgerate GmbH
  • Ocutrx Vision Technologies LLC
  • AccuVision
  • Vivid Vision Inc.
  • Fresnel Prism and Lens Co.
  • RevitalVision
  • WOW Vision Therapy

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18777

Amblyopia, commonly referred to as lazy eye, is a condition affecting the development of vision where one eye does not achieve normal visual acuity, even with corrective eyewear such as glasses or contact lenses. Typically beginning in infancy or early childhood, amblyopia occurs due to a lack of proper coordination between the eye and the brain. As time progresses, the brain starts to favor the eye with better vision, leading to further deterioration of the weaker eye.

There are several types of amblyopia strabismus amblyopia, refractive amblyopia, deprivation amblyopia, and reverse amblyopia. Strabismus amblyopia results from misalignment of the eyes, causing a discrepancy in visual acuity between them. Diagnosis involves visual acuity tests, photo screening, Bruckner tests, and others. Treatment options include the use of eye patches, atropine drops, corrective glasses, and sometimes even therapeutic video games. Amblyopia affects diverse sectors including hospital pharmacies, retail pharmacies, and online pharmacies.

The amblyopia market research report is one of a series of new reports from The Business Research Company that provides amblyopia market statistics, including amblyopia industry global market size, regional shares, competitors with a amblyopia market share, detailed amblyopia market segments, market trends and opportunities, and any further data you may need to thrive in the amblyopia industry. This amblyopia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The amblyopia market size has grown steadily in recent years. It will grow from $4.45 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The increase during the historical period can be credited to a rise in ophthalmic disorders, growing consumer demand for affordable eyewear, the prevalence of hyperopia and myopia, a larger elderly population, and increased adoption of telemedicine.

The amblyopia market size is expected to see steady growth in the next few years. It will grow to $5.59 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to the expansion of digital health platforms, increased availability of resources and parental support, greater focus on preventive healthcare for children, rising awareness about amblyopia, and the proliferation of specialized eye care centers and clinics. Key trends anticipated in this period include advancements in diagnostic technologies, development of novel treatment approaches, progress in understanding visual development and neuroplasticity, as well as the introduction and approval of new pharmaceuticals.

The increasing incidence of ophthalmological diseases is expected to drive growth in the amblyopia market moving forward. Ophthalmological diseases encompass a spectrum of disorders affecting the eyes, ranging from common ailments such as cataracts and glaucoma to rarer conditions such as retinitis pigmentosa and ocular tumors. Factors contributing to the rise in these diseases include increased screen time, aging populations, and environmental factors such as pollution. Amblyopia, in particular, can exacerbate ophthalmological conditions by causing the brain to disregard input from the weaker eye, potentially leading to permanent vision impairment and issues with depth perception if left untreated. According to the Centers for Disease Control and Prevention (CDC), over 3.4 million Americans aged 40 years and older were blind or visually impaired in January 2024, a number expected to double by 2030. Therefore, the escalating prevalence of ophthalmological diseases is a key driver behind the growth of the amblyopia market.

Major companies in the amblyopia market are prioritizing advancements in treatment technologies, such as digital therapeutics, to better cater to patients. Digital therapeutics are evidence-based interventions driven by sophisticated software programs aimed at preventing, managing, or treating medical disorders or diseases. They leverage behavioral and lifestyle changes, often facilitated by digital platforms, to enhance health outcomes and can be used independently or alongside traditional therapies. For instance, Luminopia Inc., a US-based biotechnology company, achieved FDA approval in September 2021 for its digital therapeutic, Luminopia One. This innovative treatment utilizes television shows to enhance vision in children diagnosed with amblyopia, marking the first FDA-approved digital therapeutic for a neuro-visual disorder in children and the first to employ TV shows as a treatment for amblyopia. Results from a phase 3 pivotal trial involving 105 children demonstrated a statistically significant improvement in visual acuity among those receiving treatment compared to controls, with an average improvement of 1.8 lines versus 0.8 lines, respectively. Furthermore, 62% of treated patients exhibited a robust response, defined as a 2-line or greater improvement, compared to 33% in the control group.

In October 2022, Sumitomo Corporation, a Japan-based electrical services company, partnered with Juntendo University to develop a virtual reality (VR) app for amblyopia treatment. This app aims to enhance treatment engagement and efficacy by making therapy more interactive and enjoyable for children. Juntendo University, a prominent private university in Japan, is collaborating to leverage VR technology in optimizing amblyopia treatment protocols.

Major companies operating in the amblyopia market are Novartis AG, Takeda Pharmaceutical Company Limited, Biocon Limited, Astellas Pharma Inc., Alcon Vision LLC, Bausch Health Companies Inc., HOYA Corp., UnityPoint Health, Integra LifeSciences, Wockhardt Ltd., Welch Allyn, Heidelberg Engineering Inc., Orbis International, Oculus Optikgerate GmbH, Ocutrx Vision Technologies LLC, AccuVision, Vivid Vision Inc., Fresnel Prism and Lens Co., RevitalVision, WOW Vision Therapy, Lancastle International Ltd., Novasight, Eyenovia Inc., Adaptica Srl, AmblyoPlay

North America was the largest region in the amblyopia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amblyopia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the amblyopia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amblyopia market consists of revenues earned by entities by providing services such as screening and diagnosis, vision therapy, patching therapy, and orthoptic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The amblyopia market also includes sales of contact lenses, vision therapy software, lighting products, bangerter filters, and spectacle lenses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amblyopia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amblyopia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amblyopia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amblyopia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Strabismus Amblyopia; Refractive Amblyopia; Deprivation Amblyopia; Reverse Amblyopia
  • 2) By Diagnosis: Visual Acuity Tests; Photo Screening; Bruckner Test; Other Diagnosis
  • 3) By Treatment: Eye Patches; Atropine Drops; Glasses; Video Games; Other Treatments
  • 4) By End User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
  • Companies Mentioned: Novartis AG; Takeda Pharmaceutical Company Limited; Biocon Limited; Astellas Pharma Inc.; Alcon Vision LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Amblyopia Market Characteristics

3. Amblyopia Market Trends And Strategies

4. Amblyopia Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Amblyopia Market Size and Growth

  • 5.1. Global Amblyopia Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Amblyopia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Amblyopia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Amblyopia Market Segmentation

  • 6.1. Global Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Strabismus Amblyopia
  • Refractive Amblyopia
  • Deprivation Amblyopia
  • Reverse Amblyopia
  • 6.2. Global Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Visual Acuity Tests
  • Photo Screening
  • Bruckner Test
  • Other Diagnosis
  • 6.3. Global Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Eye Patches
  • Atropine Drops
  • Glasses
  • Video Games
  • Other Treatments
  • 6.4. Global Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Amblyopia Market Regional And Country Analysis

  • 7.1. Global Amblyopia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Amblyopia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Amblyopia Market

  • 8.1. Asia-Pacific Amblyopia Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Amblyopia Market

  • 9.1. China Amblyopia Market Overview
  • 9.2. China Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Amblyopia Market

  • 10.1. India Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Amblyopia Market

  • 11.1. Japan Amblyopia Market Overview
  • 11.2. Japan Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Amblyopia Market

  • 12.1. Australia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Amblyopia Market

  • 13.1. Indonesia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Amblyopia Market

  • 14.1. South Korea Amblyopia Market Overview
  • 14.2. South Korea Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Amblyopia Market

  • 15.1. Western Europe Amblyopia Market Overview
  • 15.2. Western Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Amblyopia Market

  • 16.1. UK Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Amblyopia Market

  • 17.1. Germany Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Amblyopia Market

  • 18.1. France Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Amblyopia Market

  • 19.1. Italy Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Amblyopia Market

  • 20.1. Spain Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Amblyopia Market

  • 21.1. Eastern Europe Amblyopia Market Overview
  • 21.2. Eastern Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Amblyopia Market

  • 22.1. Russia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Amblyopia Market

  • 23.1. North America Amblyopia Market Overview
  • 23.2. North America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Amblyopia Market

  • 24.1. USA Amblyopia Market Overview
  • 24.2. USA Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Amblyopia Market

  • 25.1. Canada Amblyopia Market Overview
  • 25.2. Canada Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Amblyopia Market

  • 26.1. South America Amblyopia Market Overview
  • 26.2. South America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Amblyopia Market

  • 27.1. Brazil Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Amblyopia Market

  • 28.1. Middle East Amblyopia Market Overview
  • 28.2. Middle East Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Amblyopia Market

  • 29.1. Africa Amblyopia Market Overview
  • 29.2. Africa Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Amblyopia Market Competitive Landscape And Company Profiles

  • 30.1. Amblyopia Market Competitive Landscape
  • 30.2. Amblyopia Market Company Profiles
    • 30.2.1. Novartis AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Takeda Pharmaceutical Company Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Biocon Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Astellas Pharma Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Alcon Vision LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Amblyopia Market Other Major And Innovative Companies

  • 31.1. Bausch Health Companies Inc.
  • 31.2. HOYA Corp.
  • 31.3. UnityPoint Health
  • 31.4. Integra LifeSciences
  • 31.5. Wockhardt Ltd.
  • 31.6. Welch Allyn
  • 31.7. Heidelberg Engineering Inc.
  • 31.8. Orbis International
  • 31.9. Oculus Optikgerate GmbH
  • 31.10. Ocutrx Vision Technologies LLC
  • 31.11. AccuVision
  • 31.12. Vivid Vision Inc.
  • 31.13. Fresnel Prism and Lens Co.
  • 31.14. RevitalVision
  • 31.15. WOW Vision Therapy

32. Global Amblyopia Market Competitive Benchmarking

33. Global Amblyopia Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Amblyopia Market

35. Amblyopia Market Future Outlook and Potential Analysis

  • 35.1 Amblyopia Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Amblyopia Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Amblyopia Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer